SU(SU)
SU
Q4 2026 EPS Estimate
$1.78
Nov 3, 2026 · Reports after close
Revenue Estimate
$10.57B
FY2026E EPS$9.73
FY2027E EPS$7.54
Analyst Sentiment
Wall St. Consensus
Buy29 analysts·High coverage
70
Score
23 Buy (79%)6 Hold (21%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2379%
Hold
621%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$72.00
+6.7%
Consensus
$89.00
+31.9%
Bull
$106.00
+57.1%
12-Month Target Range29 analysts
$72.00$89.00$106.00
Current $67.47Consensus
Current Price
$67.47
Upside to Consensus
$21.53
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-8.99%
EPS-22.42%
FY2028
Rev+0.86%
EPS+5.52%
FY2029
Rev-1.37%
EPS+5.02%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $61.14B | $55.64B | $56.12B | $55.35B | $55.51B |
| Low | $58.49B | $52.01B | $51.95B | $51.73B | $51.87B |
| High | $64.92B | $58.85B | $62.09B | $59.22B | $59.39B |
| EBITDA Avg | $20.39B | $18.56B | $18.72B | $18.46B | $18.51B |
| Low | $19.51B | $17.35B | $17.33B | $17.25B | $17.30B |
| High | $21.65B | $19.63B | $20.71B | $19.75B | $19.81B |
| EBIT Avg | $12.25B | $11.15B | $11.24B | $11.09B | $11.12B |
| Low | $11.72B | $10.42B | $10.41B | $10.36B | $10.39B |
| High | $13.00B | $11.79B | $12.44B | $11.86B | $11.90B |
| Net Income Avg | $11.91B | $9.51B | $10.61B | $10.20B | $10.79B |
| Low | $11.26B | $8.55B | $6.55B | $9.33B | $9.88B |
| High | $12.57B | $10.47B | $12.41B | $11.13B | $11.78B |
| EPS Avg | $9.73 | $7.54 | $7.96 | $8.36 | $8.85 |
| Low | $9.23 | $7.01 | $5.37 | $7.65 | $8.09 |
| High | $10.30 | $8.58 | $10.17 | $9.12 | $9.65 |
| Analysts (Rev / EPS) | 4 / 7 | 7 / 7 | 6 / 6 | 4 / 3 | 3 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $14.61B | $14.42B | $14.04B | $13.82B | $13.77B | $13.72B | $13.68B | $13.31B |
| Low | $14.18B | $14.23B | $13.20B | $13.00B | $12.95B | $12.91B | $12.86B | $12.52B |
| High | $15.03B | $14.60B | $14.82B | $14.58B | $14.53B | $14.48B | $14.43B | $14.04B |
| EBITDA Avg | $4.87B | $4.81B | $4.68B | $4.61B | $4.59B | $4.58B | $4.56B | $4.44B |
| Low | $4.73B | $4.74B | $4.40B | $4.33B | $4.32B | $4.30B | $4.29B | $4.17B |
| High | $5.01B | $4.87B | $4.94B | $4.86B | $4.85B | $4.83B | $4.81B | $4.68B |
| EBIT Avg | $2.93B | $2.89B | $2.81B | $2.77B | $2.76B | $2.75B | $2.74B | $2.67B |
| Low | $2.84B | $2.85B | $2.64B | $2.60B | $2.59B | $2.59B | $2.58B | $2.51B |
| High | $3.01B | $2.93B | $2.97B | $2.92B | $2.91B | $2.90B | $2.89B | $2.81B |
| Net Income Avg | $2.89B | $2.68B | $2.20B | $1.95B | $2.18B | $2.10B | $2.24B | $2.25B |
| Low | $2.62B | $2.45B | $2.03B | $1.80B | $2.01B | $1.94B | $2.07B | $2.07B |
| High | $3.15B | $2.90B | $2.36B | $2.09B | $2.34B | $2.25B | $2.40B | $2.41B |
| EPS Avg | $2.45 | $2.27 | $1.87 | $1.65 | $1.85 | $1.78 | $1.90 | $1.91 |
| Low | $2.22 | $2.08 | $1.72 | $1.52 | $1.71 | $1.64 | $1.76 | $1.76 |
| High | $2.67 | $2.46 | $2.00 | $1.77 | $1.98 | $1.91 | $2.04 | $2.04 |
| Analysts (Rev / EPS) | 3 / 6 | 2 / 4 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 2 | 1 / 2 |